Search results for "Immune system"

showing 10 items of 2885 documents

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

2012

Background Hepatocellular carcinoma (HCC) is a typical inflammation-associated cancer, but may also provoke antitumour immune responses whose significance and underlying mechanisms are incompletely understood. Objective To characterise immune responses in the diethylnitrosamine (DEN)-liver cancer mouse model. Design Tumour development and immune cell functions upon DEN treatment were compared between C57BL/6 wild-type (WT), chemokine scavenging receptor D6-deficient, B cell- (Igh6), CD4 T cell- (MHC-II) and T-/B cell-deficient (Rag1) mice. Relevance for human HCC was tested by comparing gene array results from 139 HCC tissues. Results The induction of premalignant lesions after 24 weeks and…

MalePathologymedicine.medical_specialtyCarcinoma HepatocellularAdaptive ImmunityBiologyMajor histocompatibility complexChemokine CXCL9ArticleCCL5MiceLiver Neoplasms ExperimentalImmune systemAntigenLeukocytesmedicineAnimalsHumansCytotoxic T cellDiethylnitrosamineChemokine CCL5Chemokine CCL2B cellOligonucleotide Array Sequence AnalysisMice KnockoutB-LymphocytesMacrophagesLiver NeoplasmsGastroenterologyAcquired immune systemSurvival Analysisdigestive system diseasesMice Inbred C57BLmedicine.anatomical_structureCarcinogensDisease ProgressionCancer researchbiology.proteinPrecancerous ConditionsBiomarkersCD8T-Lymphocytes CytotoxicGut
researchProduct

Gastric and gingival localization of mucosa-associated lymphoid tissue (MALT) lymphoma. An immunohistochemical, virological and clinical case report.

1999

Non-Hodgkin's lymphomas (NHL) of the mucosa-associated lymphoid tissue (MALT) are characterized by their mucosal and glandular tissue localization. The case described here falls into the European-American classification of a low-grade B-cell lymphoma of the MALT type, with a gingival lesion 2 years after a gastric lesion. The pathogenetic mechanisms of NHL in oral MALT and the diagnosis and treatment are discussed.

MalePathologymedicine.medical_specialtyGingival NeoplasmLesionimmune system diseasesStomach Neoplasmshemic and lymphatic diseasesGastric mucosamedicineHumansGingival Neoplasmsbiologybusiness.industryRemission InductionMouth Mucosafood and beveragesMALT lymphomaLymphoma B-Cell Marginal ZoneHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.diseaseImmunohistochemistrydigestive system diseasesLymphomamedicine.anatomical_structureLymphatic systemGastric MucosaDNA ViralHerpesvirus 8 HumanPeriodonticsmedicine.symptombusinessMucosa-associated lymphoid tissueJournal of periodontology
researchProduct

Antimetastatic Effect of Immunization with Liposome-Encapsulated Tumor Cell-Membrane Proteins Obtained from Experimental Tumors

1995

Immunization of C57BL/6 mice with tumor-derived membrane-proteins encapsulated in sized liposomes (0.2 microgram/mouse) and composed by phosphatidylcholine or sphingomyelin, significantly reduced the mean values of spontaneous lung metastasis from both B16 (0.7 +/- 0.5 and 1.2 +/- 0.6, respectively) and 3LL (4.8 +/- 2.5 and 7.2 +/- 4.1, respectively) tumors, with respect to control (HEPES) groups (4.8 +/- 1.1 and 19.0 +/- 4.4, respectively). However, no significant antimetastatic effect was observed using free tumor-derived proteins (2 micrograms/mouse) or liposome vehicle alone. Specific humoral immune response after the vaccination was studied by flow cytometry of tumor cells incubated wi…

MalePathologymedicine.medical_specialtyLung NeoplasmsImmunologyMelanoma ExperimentalIn Vitro TechniquesBiologyToxicologyFlow cytometryMicechemistry.chemical_compoundImmune systemAntigens NeoplasmAntimetastatic AgentmedicineAnimalsImmunology and AllergyPharmacologyHEPESLiposomemedicine.diagnostic_testCell MembraneAntibody-Dependent Cell CytotoxicityLewis lung carcinomaGeneral MedicineMolecular biologyMice Inbred C57BLchemistryAntigens SurfaceLiposomesHumoral immunitybiology.proteinImmunizationAntibodySpleenImmunopharmacology and Immunotoxicology
researchProduct

Addition of blood to a phycogenic bone substitute leads to increased in vivo vascularization

2015

The present study aimed to analyze the effects of the addition of blood to the phycogenic bone substitute Algipore(®) on the severity of in vivo tissue reaction. Initially, Fourier-transform infrared spectroscopy (FTIR) of the bone substitute was conducted to analyze its chemical composition. The subcutaneous implantation model in Balb/c mice was then applied for up to 30 d to analyze the tissue reactions on the basis of specialized histochemical, immunohistochemical, and histomorphometrical methods. The data of the FTIR analysis showed that the phycogenic bone substitute material is mainly composed of hydroxyapatite with some carbonate content. The in vivo analyses revealed that the additi…

MalePathologymedicine.medical_specialtyMaterials scienceAngiogenesisBiomedical EngineeringNeovascularization PhysiologicBioengineeringBone tissueBiomaterialsNeovascularizationMiceImmune systemIn vivoMaterials TestingmedicineAnimalsBlood TransfusionMice Inbred BALB CRegeneration (biology)medicine.anatomical_structureConnective TissueGiant cellBone SubstitutesImmunohistochemistrymedicine.symptomBiomedical Materials
researchProduct

M2 Polarized Macrophages and Giant Cells Contribute to Myofibrosis in Neuromuscular Sarcoidosis

2011

The etiopathogenesis of sarcoidosis, a systemic granulomatous disease, still remains obscure. A multitude of organs have been described to be affected in systemic sarcoidosis. Skeletal muscles may also be affected, leading to myalgia and weakness. A workup of the specific immune response with emphasis on the macrophage response is provided herein. Affected muscle tissue from seven patients with systemic sarcoidosis was analyzed and compared with that from seven patients with other myopathies containing macrophagocytic infiltration. Monocytes/macrophages and giant cells in granulomas of muscle tissue from patients with sarcoidosis show a status of alternative activation (M2) based on their e…

MalePathologymedicine.medical_specialtySystemic diseaseSarcoidosismedicine.medical_treatmentBiologyGiant CellsMonocytesPathology and Forensic MedicineTh2 CellsImmune systemmedicineHumansMacrophageRNA MessengerMuscle SkeletalAgedGranulomaMacrophagesCCL18Cell PolarityEpithelial CellsRegular ArticleNeuromuscular DiseasesMacrophage ActivationMiddle Agedmedicine.diseaseAcquired immune systemFibrosisPhenotypeCytokineGene Expression RegulationGiant cellChemokines CCGranulomaImmunologyCytokinesFemaleThe American Journal of Pathology
researchProduct

New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study.

2011

Glaucoma is a chronic neurodegenerative disease and one of the leading causes of blindness. Autoantibody based immune processes are assumed to be involved in its pathogenesis. However, it is still unclear to what extent autoantibody patterns found in the eye (aqueous humor) are congruent to systemic autoantibodies (blood). Consistency would underline the specificity of known serum antibody markers for glaucoma. In this study we used antigen microarrays to analyze autoantibody reactivities in sera and corresponding aqueous humor samples of primary open-angle glaucoma patients (N=37) and non-glaucomatous controls (N=31). Compared to control subjects several divergent immunoreactivities were i…

MalePathologymedicine.medical_specialtygenetic structuresImmunologyGlaucomaDiseaseCataract ExtractionEyePathogenesisAqueous HumorBehavioral NeuroscienceImmune systemAntigenArtificial IntelligencemedicineHumansAntigensAgedAutoantibodiesbiologyEndocrine and Autonomic Systemsbusiness.industryMicroarray analysis techniquesAutoantibodymedicine.diseaseMicroarray Analysiseye diseasesArea Under CurveImmunoglobulin GImmunologybiology.proteinFemaleOcular Hypertensionsense organsNeural Networks ComputerAntibodybusinessAlgorithmsGlaucoma Open-AngleBrain, behavior, and immunity
researchProduct

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

2017

The natural history and its modulation by treatments administered for immune thrombocytopenia (ITP) in the clinical practice remains unknown. In addition, little information is available on the characteristics and management of ITP in Spain. We conducted an observational, multicenter, registry in 70 Hematology Services from Spain between 2009 and 2011, which included children from 2 months of age and adults with primary ITP or another ITP diagnosed within the last 6 months (platelet count [PC]  484 patients were included (median [Q1, Q3] age 52 [29,74] years, 87.6% adults), 56% women, 10.5% with secondary ITP. Median (Q1, Q3) PC at diagnosis was 12 × 109/l (4, 32); 72% of patients had bleed…

MalePediatricsRegistry studyComorbidity030204 cardiovascular system & hematologycorticosteroids0302 clinical medicineAdrenal Cortex Hormonesimmune system diseaseshemic and lymphatic diseasesRegistriesChildresponseHematologyDisease ManagementImmunoglobulins IntravenousHematologyMiddle AgedClinical PracticeNatural historyPhenotypeTreatment OutcomeIntravenous ImmunoglobulinsChild PreschoolFemaleAlgorithmsAdultmedicine.medical_specialtyAdolescentHemorrhageintravenous immunoglobulinsYoung Adult03 medical and health sciencesImmune systemInternal medicinemedicineHumansAgedPurpura Thrombocytopenic IdiopathicPlatelet Countbusiness.industryInfantImmune thrombocytopeniaImmune thrombocytopeniaSpainObservational studybusinessBiomarkers030215 immunologyHematology
researchProduct

Autoimmune hepatitis in the elderly.

2001

Abstract OBJECTIVES: Autoimmune hepatitis (AIH) is widely believed to be a disease of young women and menopause. Little is known about the frequency and clinical characteristics in patients aged ≥65 yr. METHODS: We reviewed charts of 120 consecutive outpatients with known AIH to identify patients who were diagnosed at the age of 65 or older. These 20 patients (median age, 69 yr) were compared to the same number of younger patients (median age, 24 yr) with well-documented AIH from the same cohort. RESULTS: Seventeen percent (20/120) of our patients were ≥65 yr at the time of diagnosis. In the older patients median time to diagnosis was significantly longer than in the younger patients (8.5 >…

MalePediatricsmedicine.medical_specialtyTime FactorsJaundiceAutoimmune hepatitisCohort Studiesimmune system diseasesHLA AntigensMedicineHumansAgedAutoimmune diseaseHepatitisImmunosuppression TherapyHepatologybusiness.industryIncidence (epidemiology)Gastroenterologymedicine.diseasePrognosisdigestive system diseasesMenopauseHepatitis AutoimmuneCohortImmunologyFemaleAge of onsetbusinessCohort studyThe American journal of gastroenterology
researchProduct

Leukocyte adhesion deficiency type I - a focus on oral disease in a young child

2010

This paper presents a case of the moderate form of Leukocyte adhesion deficiency type 1 (LAD-1) in a 4 year-old boy. LAD-1 is a rare, inherited immunodeficiency that affects 1 in 1 million people yearly. Affected patients are susceptible to recurrent bacterial and fungal infections, impaired pus formation and delayed wound healing. In the oral clinical finding, more important is a generalized prepuberal periodontitis that can affect the primary and permanent dentitions. For this reason cooperation between dentists and pediatricians is essential in these patients. Evaluating immune system in these patients included peripheral blood leukocyte counts, measurement of serum immunoglobulin levels…

MalePeriodontitisYoung childbusiness.industryLeukocyte-Adhesion Deficiency SyndromePrenatal diagnosismedicine.disease:CIENCIAS MÉDICAS [UNESCO]Leukocyte Adhesion Deficiency Type 1Immune systemOtorhinolaryngologyChild PreschoolUNESCO::CIENCIAS MÉDICASImmunologymedicineHumansSurgeryOral diseasePeriodontitisbusinessGeneral DentistryImmunodeficiencyLeukocyte adhesion deficiency
researchProduct

Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes.

2014

Aims Although there is still no clear definition of “adipose tissue dysfunction” or ATD, the identification of a clinical marker of altered fat distribution and function may provide the needed tools for early identification of a condition of cardiometabolic risk. Our aim was to evaluate the correlations among various anthropometric indices [BMI, Waist Circumference (WC), Hip Circumference (HC), Waist/Hip ratio (WHR), Body Adiposity Index (BAI) and Visceral adiposity Index (VAI)] and several adipocytokines [Visfatin, Resistin, Leptin, Soluble leptin receptors (sOB-R), Adiponectin, Ghrelin, Adipsin, PAI-1, vascular endothelial growth factor (VEGF), Hepatocyte growth factor (HGF) TNF-α, hs-CRP…

MalePhysiologyEpidemiologylcsh:MedicineType 2 diabetesSettore MED/13 - EndocrinologiaEndocrinologyImmune PhysiologyMedicine and Health SciencesCluster AnalysisClinical Epidemiologylcsh:ScienceAdiposityMultidisciplinaryAnthropometryLeptinVAI adipokine diabetesMiddle AgedLipidsType 2 DiabetesPhysiological ParametersResearch DesignCytokinesFemaleAnatomyResearch Articlemedicine.medical_specialtyWaistClinical Research DesignImmunologyAdipokineEndocrine SystemIntra-Abdominal FatBody adiposity indexResearch and Analysis MethodsAdipokinesInternal medicineDiabetes MellitusmedicineHumansObesityAgedNutritionDiabetic EndocrinologyAdiponectinbusiness.industryBody Weightlcsh:RBiology and Life SciencesMolecular Developmentmedicine.diseaseEndocrinologyDiabetes Mellitus Type 2ROC CurveImmune SystemMetabolic DisordersClinical ImmunologyResistinlcsh:QMetabolic syndromebusinessDevelopmental BiologyPLoS ONE
researchProduct